Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-18

Clinical Trial Update: Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing detemir to NPH insulin for gestational outcomes in pregnant individuals with type 2 diabetes mellitus; study completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPH insulin (insulin isophane)
  • detemir (insulin detemir)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2021-08-18